BMC Infectious Diseases (Sep 2022)

A modified Sequential Organ Failure Assessment score for dengue: development, evaluation and proposal for use in clinical trials

  • Angela McBride,
  • Nguyen Lam Vuong,
  • Nguyen Van Hao,
  • Nguyen Quang Huy,
  • Ho Quang Chanh,
  • Nguyen Thi Xuan Chau,
  • Nguyen Minh Nguyet,
  • Damien K. Ming,
  • Nguyen Thanh Ngoc,
  • Phung Tran Huy Nhat,
  • Nguyen Thanh Phong,
  • Luong Thi Hue Tai,
  • Phan Vinh Tho,
  • Dinh The Trung,
  • Dong Thi Hoai Tam,
  • Huynh Trung Trieu,
  • Ronald Bertus Geskus,
  • Martin J. Llewelyn,
  • C. Louise Thwaites,
  • Sophie Yacoub

DOI
https://doi.org/10.1186/s12879-022-07705-8
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background Dengue is a neglected tropical disease, for which no therapeutic agents have shown clinical efficacy to date. Clinical trials have used strikingly variable clinical endpoints, which hampers reproducibility and comparability of findings. We investigated a delta modified Sequential Organ Failure Assessment (delta mSOFA) score as a uniform composite clinical endpoint for use in clinical trials investigating therapeutics for moderate and severe dengue. Methods We developed a modified SOFA score for dengue, measured and evaluated its performance at baseline and 48 h after enrolment in a prospective observational cohort of 124 adults admitted to a tertiary referral hospital in Vietnam with dengue shock. The modified SOFA score included pulse pressure in the cardiovascular component. Binary logistic regression, cox proportional hazard and linear regression models were used to estimate association between mSOFA, delta mSOFA and clinical outcomes. Results The analysis included 124 adults with dengue shock. 29 (23.4%) patients required ICU admission for organ support or due to persistent haemodynamic instability: 9/124 (7.3%) required mechanical ventilation, 8/124 (6.5%) required vasopressors, 6/124 (4.8%) required haemofiltration and 5/124 (4.0%) patients died. In univariate analyses, higher baseline and delta (48 h) mSOFA score for dengue were associated with admission to ICU, requirement for organ support and mortality, duration of ICU and hospital admission and IV fluid use. Conclusions The baseline and delta mSOFA scores for dengue performed well to discriminate patients with dengue shock by clinical outcomes, including duration of ICU and hospital admission, requirement for organ support and death. We plan to use delta mSOFA as the primary endpoint in an upcoming host-directed therapeutic trial and investigate the performance of this score in other phenotypes of severe dengue in adults and children.

Keywords